骨髓质异质性介导肺纤维化急性恶化
相关实验视频
Updated: Jul 15, 2025

07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
128
Jennifer L Larson-Casey1, Komal Saleem1, Ranu Surolia1
1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Journal of immunology (Baltimore, Md. : 1950)
|October 2, 2023
概括
细颗粒物 (PM2.5) 暴露会通过招募炎症单细胞使异常性肺纤维化 (IPF) 恶化. 针对这些特定的单细胞可能为IPF恶化提供新的治疗策略.
科学领域:
- 环境健康 环境健康
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
背景情况:
- 颗粒物 (PM2.5) 暴露与异常性肺纤维化 (IPF) 的发展和恶化有关.
- 暴露于PM2.5会加速肺功能下降,并增加IPF患者的死亡率.
研究的目的:
- 调查PM2.5暴露在中介单细胞招募和已确定的IPF中纤维化进展中的作用.
- 确定PM2.5引起的肺纤维化恶化中涉及的特定单细胞子集.
主要方法:
- 患有已确定的纤维化病的小鼠暴露在PM2.5.5的环境中.
- 对单细胞/巨细胞异质性和炎症标志物的支气管膜洗细胞的分析.
- 评估肺空气和符合性.
- 用PM2.5.5对IPF细胞进行体外治疗.
- 针对Ly6Chi单细胞招募和收养转移实验.
主要成果:
- 暴露于PM2.5导致单细胞/巨细胞异质,具有炎症和抗炎症特征.
- 招募Ly6Chi单细胞促进了纤维化进展,减少了肺气化,并降低了肺部服从性.
- 暴露于PM2.5的小鼠的Ly6Chi单细胞显示增强了前炎性标志物.
- 针对Ly6Chi单细胞的招募抑制了纤维化进展,而它们的转移加剧了纤维化.
结论:
- 增强的Ly6Chi单细胞的招募具有亲炎性表型介导肺纤维化急性恶化.
- 向Ly6Chi单细胞代表了一种潜在的新疗法策略,用于防止IPF恶化.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Pulmonary Hypertension: Classification and Pathogenesis
207
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
207
COPD: Pathogenesis and Clinical Features
327
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
327
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cystic Fibrosis: Pathogenesis
269
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
269
Acute Respiratory Failure-II
263
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
263

